This is more of a hopeful wish on my part. I'd imagine that a preemptive dose of 2591 will not cause any safety issues especially as relates to an increase in IGF-1 simply because the natural balance of this hormone is already disturbed.
The safety profile of 2591 is very robust, but these are infants so it remains to be seen whether it's possible.
- Forums
- ASX - By Stock
- Ann: Neuren initiates development of NNZ-2591 to treat HIE
NEU
neuren pharmaceuticals limited
Add to My Watchlist
0.30%
!
$16.68

This is more of a hopeful wish on my part. I'd imagine that...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$16.68 |
Change
0.050(0.30%) |
Mkt cap ! $2.095B |
Open | High | Low | Value | Volume |
$16.80 | $16.89 | $16.66 | $525.6K | 31.33K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 68 | $16.68 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$16.71 | 126 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 60 | 16.800 |
6 | 404 | 16.790 |
2 | 173 | 16.780 |
3 | 834 | 16.770 |
2 | 148 | 16.760 |
Price($) | Vol. | No. |
---|---|---|
16.830 | 292 | 3 |
16.840 | 173 | 2 |
16.850 | 211 | 5 |
16.860 | 173 | 2 |
16.870 | 214 | 3 |
Last trade - 10.03am 31/07/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |